Sofokast Plus

Daclatasvir and Sofosbuvir Tablets 60 mg/400 mg

Send Enquiry



Categories: ,
Description

Description

COMPOSITION: Each tablet contains Sofosbuvir 400 mg + Daclatasvir 60 mg

INDICATION: SOFOKAST PLUS is a fixed dose combination of hepatitis c virus nucleotide analog NSSB polymerase inhibitor and NSSA inhibitor indicated for the treatment of:

  • Adult patients with genotype 1, 2, 3 or 4 chronic HcV inf9ction without cirrhosis or with c0mpensated cirrhosis pax of c0mbination antiviral treatment regimen.

PACKING: 28 Tablets / Bottle

Download Product PDF Attachment